Wayland, MA, United States of America

Douglas Gowers Cole

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.7

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Douglas Gowers Cole: Innovator in Targeted Therapy Development

Introduction

Douglas Gowers Cole is a notable inventor based in Wayland, MA (US). He has made significant contributions to the field of targeted therapy development, holding 2 patents that focus on enhancing immune response and developing personalized therapeutic modalities.

Latest Patents

Cole's latest patents include "Systems and methods for patient targeted therapy development." This invention describes platforms designed for targeted therapy development tailored to individuals or groups. The second patent, "Methods of modulating immune activity," provides innovative methods for increasing immune response through the administration of specific agents. These methods aim to improve treatment outcomes for infections and cancer by utilizing postcellular signaling factors and various receptor agonists and antagonists.

Career Highlights

Throughout his career, Douglas Gowers Cole has worked with prominent companies such as Flagship Pioneering Innovations VI, LLC and Flagship Pioneering Innovations V, Inc. His work has been instrumental in advancing therapeutic strategies that are both effective and personalized.

Collaborations

Cole has collaborated with notable professionals in his field, including Aaron Garth Day-Williams and Anthony Michael Barsotti. These collaborations have contributed to the development of innovative solutions in targeted therapy.

Conclusion

Douglas Gowers Cole's work in targeted therapy development showcases his commitment to advancing medical science through innovation. His patents reflect a deep understanding of immune modulation and personalized medicine, positioning him as a key figure in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…